Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry.
Russo Russo(University of Campania "Luigi Vanvitelli"), Antonio D’Onofrio(Istituto Nazionale di Fisica Nucleare, Sezione di Napoli), Gerardo Nigro(University of Campania "Luigi Vanvitelli"), Lucio Santangelo(Società Italiana di Cardiologia), Filipo Vecchione, Paolo Calabrò(University of Campania "Luigi Vanvitelli"), Bianchi, C. Cavallaro, Berardo Sarubbi(Parthenope University of Naples), De Vivo S
PubMed
October 1, 2015
Cited by 40
Related Papers
Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension
|International Journal of Cardiology|2013|242
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry
|Cardiovascular Diabetology|2022|206
Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension
|CHEST Journal|2019|147
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry
|Pharmacological Research|2022|146
Enhanced electron screening in d(d,p)t for deuterated metals
|The European Physical Journal A|2004|144